1. Cancer-Associated Thrombosis

3. Cancer-Associated Thrombosis Who Is at Risk?

4. Cancer-Associated Thrombosis How to Identify Those at Risk

5. Risk of VTE in Medical Patients

6. Primary Prevention Trials

7. Bleeding Risk in Patients With Cancer

8. Treating the Patient With VTE

9. How Long to Treat?

10. NOACs vs LMWH in Patients With Cancer

11. Study Results

12. LMWH and VKAs

13. Study Results (cont)

14. Patient Persistence With Anticoagulation LMWH vs Oral Agents

15. Challenges of Anticoagulation Therapy

16. Ottawa Risk Score

17. Tailoring Treatment

18. ISTH Guidance Statement

19. CARAVAGGIO

20. Managing Anticoagulation

21. Managing Anticoagulation (cont)

22. Summary

23. Abbreviations